GlassScriptPhysician profile
Medhat Chowdhury
NPI 1386139988
$8,279.76
in general payments reported to CMS, 2019-2025
26 companies · $5,177 in 2025
The $5,177 reported for 2025 was more than what 98% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $496 · 2023: $1,003 · 2024: $1,604 · 2025: $5,177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,310 · Travel and Lodging: $1,474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,310.01 |
| Travel and Lodging | $1,473.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,573.58 | 2022-2025 | Optis, Ensite, Xience Skypoint |
| Amgen INC. | $792.63 | 2023-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $557.04 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $376.02 | 2025 | |
| Stryker Corporation | $372.98 | 2025 | Flowtriever, Clottriever Bold Catheter |
| Kestra Medical Technology Services, INC. | $350.12 | 2025 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $265.41 | 2024-2025 | Jardiance |
| Chiesi USA, INC. | $247.56 | 2024-2025 | Kengreal, Cleviprex |
| Boston Scientific Corporation | $233.95 | 2025 | General - Vascular Access, Watchman Flx |
| Genzyme Corporation | $233.32 | 2022-2023 | |
| Medtronic, INC. | $221.77 | 2023-2025 | In.Pact Admiral, Symplicity G3, Cobalt Dr Mri Surescan |
| Inari Medical, INC. | $162.64 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Edwards Lifesciences Corporation | $145.20 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Penumbra, INC. | $142.57 | 2024 | Penumbra System |
| Novo Nordisk INC | $116.65 | 2025 | Ozempic |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $110.56 | 2023 | |
| Teleflex LLC | $83.18 | 2025 | Guideliner, Turnpike |
| Astrazeneca Pharmaceuticals LP | $64.87 | 2024-2025 | Wainua |
| Pfizer INC. | $60.09 | 2023-2024 | |
| Imperative Care, INC | $39.96 | 2025 | Symphony Catheter |
| Kiniksa Pharmaceuticals International, Plc | $37.11 | 2024 | Arcalyst |
| Lantheus Medical Imaging, INC. | $22.59 | 2023 | Definity |
| Heartflow, INC. | $20.59 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.35 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $16.93 | 2023 | Inpefa |
| Novartis Pharmaceuticals Corporation | $14.09 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Medhat Chowdhury listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.